Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential Thrombocytopenia”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)UnknownNCT05395507
What this trial is testing

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

Who this might be right for
Essential Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 194
Large-scale testing (Phase 3)Active Not RecruitingNCT03165734
What this trial is testing

Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum 407
Large-scale testing (Phase 3)Ended earlyNCT02055781
What this trial is testing

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
CTI BioPharma 311
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07447817
What this trial is testing

Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

Who this might be right for
MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
John Mascarenhas 26
Large-scale testing (Phase 3)Ended earlyNCT01773187
What this trial is testing

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
CTI BioPharma 327
Very early researchWithdrawnNCT02805868
What this trial is testing

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
MyelofibrosisPolycythemia VeraPrimary Myelofibrosis+1 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT00931762
What this trial is testing

Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraPost-Essential Thrombocytopenia
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)UnknownNCT04226950
What this trial is testing

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

Who this might be right for
Essential Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Not applicableNo Longer AvailableNCT05582083
What this trial is testing

Managed Access Program for Momelotinib in Myelofibrosis

Who this might be right for
MyelofibrosisPrimary Myelofibrosis
GlaxoSmithKline
Testing effectiveness (Phase 2)Ended earlyNCT04854096
What this trial is testing

Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
NS Pharma, Inc. 7